Spray-Dried Hierarchical Aggregates of Iron Oxide Nanoparticles and Their Functionalization for Downstream Processing in Biotechnology.

Spray-Dried Hierarchical Aggregates of Iron Oxide Nanoparticles and Their Functionalization for Downstream Processing in Biotechnology.

In this work, the structuring of iron oxide nanoparticles by way of spray-drying (SD) of aqueous suspensions is investigated, resulting in micrometer-sized aggregates with saturation magnetization corresponding to that of the person nanoparticles. Interestingly, the superparamagnetic conduct is retained regardless of the multicore construction.

Modification of the aggregates by way of the addition of silica nanoparticles to the suspension permits for management of the ensuing magnetization by adjusting the iron oxide content material. Moreover, the morphology of the produced aggregates is progressively shifted from irregular inflated-like shapes in case of pure iron oxide aggregates to succeed in spherical constructions when bringing the silica content material to solely 20%. The aggregates with completely different magnetization could be successfully separated in a easy column with an connected everlasting magnet.

Functionalization of pure iron oxide aggregates with a beforehand coupled ligand holding a nitrilotriacetic acid (NTA)-like moiety and subsequent loading with Ni2+ ions results in the flexibility to bind 6-histidine (His6)-tagged goal proteins by way of chelation complexes for magnetic separation. The utility of the introduced system for the purification of recombinant protein A in a number of cycles is proven. The recyclability of the separation system in mixture with the excessive diploma of magnetic separation is promising for future functions in the sector of preparative in situ protein purification.

Biocatalysts present a significant benefit to bio-based financial system over chemical catalysts by catalyzing varied helpful transformations in an atmosphere pleasant method together with different main advantages of selectivity, specificity, and low power consumption. Since final decade, cellulase is the third highest used enzyme in business in varied processes. Xylanase can also be one among the extensively used enzymes, and many industrial functions require synergistic motion of each of these enzymes. These functions predominantly embody bioethanol manufacturing, deinking of waste paper, animal feed processing, meals processing, paper and pulp manufacturing, removing of high-quality fibers from textile materials (biostoning), and prescription drugs.

These enzymes are produced by microorganisms (fungi and micro organism), and therefore, the microorganisms producing each cellulases and xylanases are in excessive demand by these industries. This assessment focuses on the synergistic functions of cellulase and xylanase enzymes throughout varied industrial sectors. It additionally discusses the potential functions and the necessity of the microbial programs (fungi and micro organism) secreting each of these enzymes and the longer term prospects of their improvement into an integral half of varied industrial processes.

DAR-1

GW7529-5 5
EUR 284.3

DAR-2

GW8659-1 1
EUR 205.8

DAR-2

GW8659-25 25
EUR 1546.3

DAR-2

GW8659-5 5
EUR 423.4

DAR-4T

GW1186-1 1
EUR 388.8

DAR-4T

GW1186-5 5
EUR 1436.2

DAR-1T

GW5595-1 1
EUR 371.1

DAR-1T

GW5595-5 5
EUR 1365.9

DAR-2T

GW5966-1 1
EUR 222.3

DAR-2T

GW5966-5 5
EUR 475.7

DAR-4M

GW9829-1 1
EUR 388.8

DAR-4M

GW9829-5 5
EUR 1436.2

DAR-4MT

GW2770-1 1
EUR 388.8

DAR-4MT

GW2770-5 5
EUR 1436.2

DAR-2 Solution

GW5599-1 1
EUR 720.6

DAR-4 Solution

GW6996-1 1
EUR 720.6

DAR-1 Solution

GW9719-1 1
EUR 720.6

DAR-1T Solution

GW0136-1 1
EUR 720.6

DAR-4T Solution

GW2484-1 1
EUR 720.6

DAR-4M Solution

GW9618-1 1
EUR 720.6

DAR-4MT Solution

GW2711-1 1
EUR 720.6

Dar/ Rat Dar ELISA Kit

ELI-34283r 96 Tests
EUR 1063.2

Dars/ Rat Dars ELISA Kit

ELI-46226r 96 Tests
EUR 1063.2

Dars2/ Rat Dars2 ELISA Kit

ELI-29268r 96 Tests
EUR 1063.2

Tips 50ul 103 mm dark green 10x96

E0030073630 EACH
EUR 91.2

DARPP32 (DARPP32) Antibody

abx232244-100ug 100 ug
EUR 577.2

DARPP32 (DARPP32) Antibody

abx037707-100ug 100 ug
EUR 469.2

Tips PCR Clean 50uL 103 mm dark green 10x96

E0030073649 EACH
EUR 100.8

KRIBIOLISA™ Daratumumab (DARZALEX™) ELISA

KBI1028 12 × 8 wells
EUR 2133

DAR-M

GW1128-1 1
EUR 388.8

DAR-M

GW1128-5 5
EUR 1436.2

[D-Arg25]-Neuropeptide Y, human, rat; [D-Arg25]-NPY, human, rat

5-00108 4 x 1mg Ask for price

DAR-MT

GW1738-1 1
EUR 388.8

DAR-MT

GW1738-5 5
EUR 1436.2

Shikari (Q-DAR) Daratumumab (Darzalex)Free drug ELISA kit

DAR-FD-DAR 1x96-wells test plate
EUR 1053.6
Description: Enzyme Immunoassay for detection of freeDaratumumab (Darzalex) in human serum and plasma samples.

D3-βArr

HY-124867 50mg
EUR 721.2

DARC siRNA

20-abx913572
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

DARC siRNA

20-abx913573
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

DARS siRNA

20-abx913576
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

DARS siRNA

20-abx913577
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

DARS siRNA

20-abx901412
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

DARPP-32

RA18015 100 ul
EUR 579.6

DARS2 siRNA

20-abx913574
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

DARS2 siRNA

20-abx913575
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

DARS2 siRNA

20-abx901411
  • EUR 661.20
  • EUR 878.40
  • 15 nmol
  • 30 nmol

darkroom

VLCN6 ea
EUR 321.6

Darunavir

10-021 50 mg
EUR 501.36
Description: Darunavir is a highly potent HIV protease inhibitor (IC50=3-6nM, depending on laboratory HIV-1 strain), an antiretroviral medication used to treat and prevent HIV/AIDS. Darunavir is a second generation HIV-1 protease inhibitor that inhibits replication of various laboratory strains and clinical isolates of HIV-1, including those resistant to first generation protease inhibitors. It inhibits cell-free diffusion and cell-to-cell spread of HIV-1 in Jurkat cell populations. Formulations containing darunavir have been used in combination therapy for the treatment of HIV. The Darunavir ethanolate (Prod. No. AG-CR1-3724) formulation has some stability advantages compared to the free base Darunavir. Shown in a SARS-CoV-2 protease structure model study to potentially bind and inhibit the papain-like viral protease (PLVP) of SARS-CoV-2, responsible for COVID-19.

DARC Peptide

4069P 0.05 mg
EUR 197.7
Description: (CT) DARC peptide

DARC Peptide

4071P 0.05 mg
EUR 197.7
Description: (NT) DARC peptide

DARS Rabbit pAb

A6574-100ul 100 ul
EUR 369.6

DARS Rabbit pAb

A6574-200ul 200 ul
EUR 550.8

DARS Rabbit pAb

A6574-20ul 20 ul
EUR 219.6

DARS Rabbit pAb

A6574-50ul 50 ul
EUR 267.6

Darunavir

A8206-5 5 mg
EUR 142.8
Description: Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions.

Darunavir

A8206-5.1 10 mM (in 1mL DMSO)
EUR 254.4
Description: Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions.

Darunavir

A8206-50 50 mg
EUR 518.4
Description: Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions.

Darunavir

A8206-S Evaluation Sample
EUR 97.2
Description: Darunavir is an orally-bioavailable non-peptidic inhibitor of human immunodeficiency virus type 1 (HIV-1) protease that selectively inhibits HIV-1 protease enzyme induced cleavage of gag and gag-pol poly-proteins preventing the maturation of virions.

D-Arabitol

AB0097 25g
EUR 310.56

D-Arabitol

HY-N3686 10mM/1mL
EUR 135.6

Darunavir

HY-17040 5mg
EUR 300

D-Arginine

GM7267-1G 1 g
EUR 69.6

D-Arginine

GM7267-25G 25 g
EUR 246

D-Arginine

GM7267-5G 5 g
EUR 112.8

D-Arginine

GM7267-1 1
EUR 27.8

D-Arginine

GM7267-25 25
EUR 174

D-Arginine

GM7267-5 5
EUR 63.3

Darunavir

GP5767-10 10
EUR 67.2

Darunavir

GP5767-50 50
EUR 234.9

Shikari (S-ATDAR) Daratumumab (Darzalex) Qualitative ELISA kit

DAR-QLS-DAR 1x96-wells test plate
EUR 999
Description: Enzyme Immunoassay for Qualitative detection of Daratumumab (Darzalex) in human serum and plasma samples.

Darapladib

B1265-25 each
EUR 705.6

Darapladib

B1265-5 each
EUR 222

DARC Antibody

24507-100ul 100ul
EUR 468

DARC Antibody

24508-100ul 100ul
EUR 468

DARS antibody

39018-100ul 100ul
EUR 302.4

DARC Antibody

4069-002mg 0.02 mg
EUR 206.18
Description: DARC Antibody: DARC, also known as the Duffy antigen/chemokine receptor, is a seven-transmembrane protein homologous to the classical chemokine G-protein coupled receptors (GPCRs) with the exception of the motif required for G protein coupling. DARC can bind with high affinity several chemokines without transducing any signal, suggesting it may modulate the signals normally induced by these chemokines. Recently, DARC was found to interact with KAI1, a four transmembrane protein recently identified as a tumor metastasis suppressor protein. It is thought that tumor cells dislodged from the primary tumor and expressing KAI1 interact with DARC proteins expressed on vascular cells, transmitting a senescent signal to the tumor cells, while tumor cells that have lost KAI1 expression can proliferate and potentially give rise to metastases. At least three isoforms of DARC are known to exist.

DARC Antibody

4069-01mg 0.1 mg
EUR 523.7
Description: DARC Antibody: DARC, also known as the Duffy antigen/chemokine receptor, is a seven-transmembrane protein homologous to the classical chemokine G-protein coupled receptors (GPCRs) with the exception of the motif required for G protein coupling. DARC can bind with high affinity several chemokines without transducing any signal, suggesting it may modulate the signals normally induced by these chemokines. Recently, DARC was found to interact with KAI1, a four transmembrane protein recently identified as a tumor metastasis suppressor protein. It is thought that tumor cells dislodged from the primary tumor and expressing KAI1 interact with DARC proteins expressed on vascular cells, transmitting a senescent signal to the tumor cells, while tumor cells that have lost KAI1 expression can proliferate and potentially give rise to metastases. At least three isoforms of DARC are known to exist.

DARC Antibody

4071-002mg 0.02 mg
EUR 206.18
Description: DARC Antibody: DARC, also known as the Duffy antigen/chemokine receptor, is a seven-transmembrane protein homologous to the classical chemokine G-protein coupled receptors (GPCRs) with the exception of the motif required for G protein coupling. DARC can bind with high affinity several chemokines without transducing any signal, suggesting it may modulate the signals normally induced by these chemokines. Recently, DARC was found to interact with KAI1, a four transmembrane protein recently identified as a tumor metastasis suppressor protein. It is thought that tumor cells dislodged from the primary tumor and expressing KAI1 interact with DARC proteins expressed on vascular cells, transmitting a senescent signal to the tumor cells, while tumor cells that have lost KAI1 expression can proliferate and potentially give rise to metastases. At least three isoforms of DARC are known to exist.

DARC Antibody

4071-01mg 0.1 mg
EUR 523.7
Description: DARC Antibody: DARC, also known as the Duffy antigen/chemokine receptor, is a seven-transmembrane protein homologous to the classical chemokine G-protein coupled receptors (GPCRs) with the exception of the motif required for G protein coupling. DARC can bind with high affinity several chemokines without transducing any signal, suggesting it may modulate the signals normally induced by these chemokines. Recently, DARC was found to interact with KAI1, a four transmembrane protein recently identified as a tumor metastasis suppressor protein. It is thought that tumor cells dislodged from the primary tumor and expressing KAI1 interact with DARC proteins expressed on vascular cells, transmitting a senescent signal to the tumor cells, while tumor cells that have lost KAI1 expression can proliferate and potentially give rise to metastases. At least three isoforms of DARC are known to exist.

DARS Antibody

43072-100ul 100ul
EUR 302.4

Darapladib

A3349-25 25 mg
EUR 630
Description: Plaque rupture is responsible for the clinical events of ischemic death, myocardial infarction, acute coronary syndromes and ischemic strokes. Lipoprotein-associated phospholipase A2 (Lp-PLA2) seems to play a major role in the development of such high-risk lesions.

Darapladib

A3349-5 5 mg
EUR 201.6
Description: Plaque rupture is responsible for the clinical events of ischemic death, myocardial infarction, acute coronary syndromes and ischemic strokes. Lipoprotein-associated phospholipase A2 (Lp-PLA2) seems to play a major role in the development of such high-risk lesions.

Darapladib

A3349-5.1 10 mM (in 1mL DMSO)
EUR 313.2
Description: Plaque rupture is responsible for the clinical events of ischemic death, myocardial infarction, acute coronary syndromes and ischemic strokes. Lipoprotein-associated phospholipase A2 (Lp-PLA2) seems to play a major role in the development of such high-risk lesions.

D-Arabinose

abx082206-5g 5 g
EUR 226.8

DARS antibody

70R-16739 50 ul
EUR 522
Description: Rabbit polyclonal DARS antibody

DARS2 Rabbit pAb

A7813-100ul 100 ul
EUR 369.6

DARS2 Rabbit pAb

A7813-200ul 200 ul
EUR 550.8

DARS2 Rabbit pAb

A7813-20ul 20 ul
EUR 219.6

DARS2 Rabbit pAb

A7813-50ul 50 ul
EUR 267.6

D-Arabinose

AB0071D 25g
EUR 84.01

DARS2 Rabbit pAb

A4814-100ul 100 ul
EUR 369.6

DARS2 Rabbit pAb

A4814-200ul 200 ul
EUR 550.8

DARS2 Rabbit pAb

A4814-20ul 20 ul
EUR 219.6

DARS2 Rabbit pAb

A4814-50ul 50 ul
EUR 267.6

DARS Antibody

1-CSB-PA006505GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against DARS. Recognizes DARS from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB

DARS Antibody

1-CSB-PA006505LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against DARS. Recognizes DARS from Human. This antibody is Unconjugated. Tested in the following application: ELISA

DARS Antibody

DF14335 100ul
EUR 420

DARC Antibody

DF13554 100ul
EUR 420

D-Arabinose

GC6439-100G 100 g
EUR 180

D-Arabinose

GC6439-25G 25 g
EUR 78

D-Arabinose

GC6439-500G 500 g
EUR 322.8

D-Arabinose

GC6439-50G 50 g
EUR 129.6

Darutoside

HY-N6028 10mg
EUR 614.4

Darodipine

HY-U00086 1mg
EUR 555.6

Darapladib

HY-10521 50mg
EUR 1695.6

Darusentan

HY-15404 100mg
EUR 1575.6

D-arabinose

HY-N0059 5g
EUR 142.8

DARC Antibody

R34265-100UG 100 ug
EUR 339.15
Description: Additional name(s) for this target protein: Duffy blood group / FY

Darutoside

TB00518 20mg
EUR 529.2

DAR-M Solution

GW7701-1 1
EUR 720.6

darkroom 254/254nm

VLCN15-CC ea
EUR 1842

darkroom 254/365nm

VLCN15-LC ea
EUR 1842

darkroom 365/365nm

VLCN15-LL ea
EUR 1842

darkroom 365/312nm

VLCN15-LM ea
EUR 1842

darkroom 312/312nm

VLCN15-MM ea
EUR 1842

D-Arabinose

GC6439-100 100
EUR 118.7

D-Arabinose

GC6439-25 25
EUR 34.8

D-Arabinose

GC6439-50 50
EUR 65.9

D-Arabinose

GC6439-500 500
EUR 237.2

DARS2 antibody

70R-16740 50 ul
EUR 522
Description: Rabbit polyclonal DARS2 antibody

DARS protein (His tag)

80R-2197 100 ug
EUR 386.4
Description: Purified recombinant Human DARS Protein (His tag)

DARPP- 32 Antibody

ABF6487 100 ug
EUR 525.6

DARPP- 32 Antibody

ABF6488 100 ug
EUR 525.6

DARS2 Antibody

DF12593 200ul
EUR 420

DARS2 Antibody

1-CSB-PA006506GA01HU
  • EUR 716.40
  • EUR 399.60
  • 150ul
  • 50ul
Description: A polyclonal antibody against DARS2. Recognizes DARS2 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC

DARS2 Antibody

1-CSB-PA747490LA01HU
  • EUR 380.40
  • EUR 402.00
  • 100ug
  • 50ug
Description: A polyclonal antibody against DARS2. Recognizes DARS2 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200

DARS1 Antibody

F54347-0.08ML 0.08 ml
EUR 140.25
Description: Aspartyl-tRNA synthetase (DARS) is part of a multienzyme complex of aminoacyl-tRNA synthetases. Aspartyl-tRNA synthetase charges its cognate tRNA with aspartate during protein biosynthesis.

DARS1 Antibody

F54347-0.4ML 0.4 ml
EUR 322.15
Description: Aspartyl-tRNA synthetase (DARS) is part of a multienzyme complex of aminoacyl-tRNA synthetases. Aspartyl-tRNA synthetase charges its cognate tRNA with aspartate during protein biosynthesis.

Ab Rabbit DARPP-32*

P40003-100uL 100uL Ask for price

DARC ELISA KIT|Human

EF009010 96 Tests
EUR 826.8

DARS ELISA KIT|Human

EF009012 96 Tests
EUR 826.8

Darbufelone

HY-101438 1mg
EUR 391.2

Darifenacin

HY-A0033 10mg
EUR 223.2

Darenzepine

HY-100154 10mg
EUR 2264.4

DARS2 Antibody

RQ4930 100ug
EUR 356.15
Description: DARS2 contains conserved residues involved in ATP binding, tRNA binding, and aspartic acid recognition, as well as catalytic site motifs characteristic of amino acid tRNA synthetases. The protein encoded by this gene belongs to the class-II aminoacyl-tRNA synthetase family. It is a mitochondrial enzyme that specifically aminoacylates aspartyl-tRNA. Mutations in this gene are associated with leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL). The International Radiation Hybrid Mapping Consortium mapped the DARS2 gene to chromosome 1.

Darutigenol

TB00531 20mg
EUR 529.2

D-arabinitol

TB00689 4X25mg
EUR 321.6

DAR-MT Solution

GW3215-1 1
EUR 720.6

Darifenacin HBr

B1600-10 10 mg
EUR 142.8
Description: DarifenacinHBr(UK88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9 [1]. Themuscarinic acetylcholine receptor, also known as cholinergic/acetylcholine receptor M3, or themuscarinic 3, is amuscarinic acetylcholine receptorencoded by the human geneCHRM3.

Darifenacin HBr

B1600-100 100 mg
EUR 630
Description: DarifenacinHBr(UK88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9 [1]. Themuscarinic acetylcholine receptor, also known as cholinergic/acetylcholine receptor M3, or themuscarinic 3, is amuscarinic acetylcholine receptorencoded by the human geneCHRM3.

Darifenacin HBr

B1600-1000 1 g
EUR 1144.8
Description: DarifenacinHBr(UK88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9 [1]. Themuscarinic acetylcholine receptor, also known as cholinergic/acetylcholine receptor M3, or themuscarinic 3, is amuscarinic acetylcholine receptorencoded by the human geneCHRM3.

Darifenacin HBr

B1600-5.1 10 mM (in 1mL DMSO)
EUR 157.2
Description: DarifenacinHBr(UK88525) is a selective M3 muscarinic receptor antagonist with pKi of 8.9 [1]. Themuscarinic acetylcholine receptor, also known as cholinergic/acetylcholine receptor M3, or themuscarinic 3, is amuscarinic acetylcholine receptorencoded by the human geneCHRM3.

Darglitazone

C4758-10 10 mg
EUR 351.6

Darglitazone

C4758-25 25 mg
EUR 686.4

Darglitazone

C4758-5 5 mg
EUR 216

DARP32 antibody

70R-30567 100 ug
EUR 392.4
Description: Rabbit polyclonal DARP32 antibody

Leave a Comment

Your email address will not be published.

Scroll to Top